Scopus Biopharma Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Scopus Biopharma current Real Value cannot be determined due to lack of data. The regular price of Scopus Biopharma is $0.0. Our model measures the value of Scopus Biopharma from inspecting the company fundamentals such as Return On Equity of -15.6, shares outstanding of 21.09 M, and Shares Owned By Institutions of 2.15 % as well as reviewing its technical indicators and probability of bankruptcy. . In general, most investors recommend acquiring undervalued stocks and selling overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Scopus Biopharma Total Value Analysis
Scopus Biopharma is at this time projected to have valuation of 1.18 M with market capitalization of 2.17 M, debt of 2.54 M, and cash on hands of 1.16 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Scopus Biopharma fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.18 M | 2.17 M | 2.54 M | 1.16 M |
Scopus Biopharma Asset Utilization
One of the ways to look at asset utilization of Scopus is to check how much profit was generated for every dollar of assets it reports. Scopus Biopharma has a negative utilization of assets of -4.61 %, losing $0.0461 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Scopus Biopharma shows how discouraging it operates for each dollar spent on its assets.Scopus Biopharma Ownership Allocation
Scopus Biopharma shows a total of 21.09 Million outstanding shares. Scopus Biopharma maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Scopus Biopharma Profitability Analysis
Net Loss for the year was (26.95 M) with profit before overhead, payroll, taxes, and interest of 0.Scopus Biopharma Growth Indicators
Investing in growth stocks can be very risky. If the company such as Scopus Biopharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 13.4 M | |
| Retained Earnings | -41.5 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Scopus OTC Stock
If you are still planning to invest in Scopus Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Scopus Biopharma's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |